These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 36198551)
1. [Allogeneic hematopoietic cell transplantation for myelofibrosis: current status and future challenges]. Takagi S Rinsho Ketsueki; 2022; 63(9):1252-1260. PubMed ID: 36198551 [TBL] [Abstract][Full Text] [Related]
2. Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment. Gergis U; Kuriakose E; Shore T; Mayer S; Mark T; Pearse R; Schuster M; Feldman E; Roboz G; Ritchie E; Scandura J; Wang H; Zhou XK; Silver RT; van Besien K Clin Lymphoma Myeloma Leuk; 2016 May; 16(5):297-303. PubMed ID: 27025789 [TBL] [Abstract][Full Text] [Related]
3. Splenic irradiation as a component of a reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in myelofibrosis with massive splenomegaly. Ito T; Akagi K; Kondo T; Kawabata H; Ichinohe T; Takaori-Kondo A Tohoku J Exp Med; 2012 Dec; 228(4):295-9. PubMed ID: 23117264 [TBL] [Abstract][Full Text] [Related]
4. Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation. Ciurea SO; Sadegi B; Wilbur A; Alagiozian-Angelova V; Gaitonde S; Dobogai LC; Akard LP; Hoffman R; Rondelli D Br J Haematol; 2008 Apr; 141(1):80-3. PubMed ID: 18324970 [TBL] [Abstract][Full Text] [Related]